Advise the patient to read the Patient Information.
Pregnancy: Advise female patients of childbearing age about the consequences of exposure to COZAAR during pregnancy. Discuss treatment options with women planning to become pregnant. Tell patients to report pregnancies to their physicians as soon as possible [see Fetal Toxicity under Precautions and Pregnancy under Use in Pregnancy & Lactation].
Potassium Supplements: Advise patients receiving COZAAR not to use potassium supplements or salt substitutes containing potassium without consulting their healthcare provider [see Agents Increasing Serum Potassium under Interactions].